Neuroone Medical Technologies is trading at $1.78, up 10.56%, with the move appearing mainly linked to stronger healthcare-sector sentiment; healthcare rose 1.37% during regular trading.
- No new company-specific announcement was identified for September 2, 2026.
- Recent fiscal Q3 results showed 16% revenue growth and 43% higher orders, but were released in August and do not directly explain today’s catalyst.
- Broader equity markets are also higher, supporting risk appetite.